Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies.
about
Olaparib does not cause clinically relevant QT/QTc interval prolongation in patients with advanced solid tumours: results from two phase I studies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Olaparib does not cause clinic ...... ults from two phase I studies.
@en
Olaparib does not cause clinic ...... ults from two phase I studies.
@nl
type
label
Olaparib does not cause clinic ...... ults from two phase I studies.
@en
Olaparib does not cause clinic ...... ults from two phase I studies.
@nl
prefLabel
Olaparib does not cause clinic ...... ults from two phase I studies.
@en
Olaparib does not cause clinic ...... ults from two phase I studies.
@nl
P2093
P2860
P1476
Olaparib does not cause clinic ...... ults from two phase I studies.
@en
P2093
Anitra Fielding
Corina Dota
Helen Swaisland
Marc-Antoine Fabre
Ruth Plummer
Sally Garnett
Wendy Bannister
P2860
P2888
P304
P356
10.1007/S00280-016-3124-5
P577
2016-08-23T00:00:00Z